Involvement of cannabinoid receptors in gut motility and visceral perception
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
From a historical perspective to the present day, all the evidence suggests that activation of cannabinoid receptors (CBRs) is beneficial for gut discomfort and pain, which are symptoms related to dysmotility and visceral perception. CBRs comprise G‐protein coupled receptors that are predominantly in enteric and central neurones (CB1R) and immune cells (CB2R). In the last decade, evidence obtained from the use of selective agonists and inverse agonists/antagonists indicates that manipulation of CB1R can alter (1) sensory processing from the gut, (2) brain integration of brain‐gut axis, (3) extrinsic control of the gut and (4) intrinsic control by the enteric nervous system. The extent to which activation of CB1R is most critical at these different levels is related to the region of the GI tract. The upper GI tract is strongly influenced by CB1R activation on central vagal pathways, whereas intestinal peristalsis can be modified by CB1R activation in the absence of extrinsic input. Actions at multiple levels make the CB1R a target for the treatment of functional bowel disorders, such as IBS. Since low‐grade inflammation may act as a trigger for occurrence of IBS, CB2R modulation could be beneficial, but there is little supporting evidence for this yet. The challenge is to accomplish CBR activation while minimizing adverse effects and abuse liabilities. Potential therapeutic strategies involve increasing signaling by endocannabinoids (EC). The pathways involved in the biosynthesis, uptake and degradation of EC provide opportunities for modulation of CB1R and some recent evidence with inhibitors of EC uptake and metabolism suggest that these could be exploited for therapeutic gain. British Journal of Pharmacology (2004) 141, 1335–1345. doi:10.1038/sj.bjp.0705783
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 8×
“CB2R-immunoreactivity was not visualized in the rat stomach by using a human CB2R antibody (Adami et al., 2002) and activation of CB2R selectively did not attenuate basal or stimulated gastric acid secretion (Coruzzi et al., 1999; Adami et al., 2002).”
BackgroundInfluentialMechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“The monoglyceride, 2-arachidonoylglycerol (2-AG) is even more abundant in brain tissue than AEA, and may be more potent at CB2R than AEA (Mechoulam et al., 1995; Sugiura et al., 2000).”
BackgroundBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“Although 2-AG can be hydrolyzed by FAAH, it is largely metabolized by monoacylglycerol lipase (Goparaju et al., 1999; Dinh et al., 2002).”
BackgroundCannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610 · cited 1×
“The antiemetic effect of delta9-THC and related compounds has been confirmed clinically (Tramer et al., 2001).”
BackgroundHohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00524-7 · Cited by 301
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152 · cited 1×
“Additionally, blockade of British Journal of Pharmacology vol 141 (8) endogenous EC with rimonibant precipitates diarrhea in morphine-dependent rats (Navarro et al., 1998).”
BackgroundBisogno, T., Petrocellis, L., & Marzo, V. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395655 · Cited by 112 · cited 15×
“Briefly, FAAH is a membraneassociated protein that is localized to internal membranes, such as the endoplasmic reticulum, where it is active (Figure 3).”
BackgroundInfluentialCichewicz, D. L., & Welch, S. P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046870 · Cited by 110
Costa, B., Colleoni, M., Conti, S., Trovato, A. E., Bianchi, M., Sotgiu, M. L., & Giagnoni, G. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705587 · Cited by 89 · cited 1×
“…it has been shown in other systems, such as a neuropathic pain model, that WIN 55,212-2 reduces the hyperalgesia that develops after sciatic nerve ligation and British Journal of Pharmacology vol 141 (8) reduces the levels of pronociceptive substances, such as prostaglandin E2 (Costa et al., 2004).”
Background
Cited by
Artmann, A., Petersen, G., Hellgren, L. I., Boberg, J., Skonberg, C., Nellemann, C., Hansen, S. H., & Hansen, H. S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.01.006 · Cited by 287
Wright, K. L., Duncan, M., & Sharkey, K. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 264
Brusberg, M., Arvidsson, S., Kang, D., Larsson, H., Lindström, E., & Martinez, V. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5166-08.2009 · Cited by 88
“A limited number of studies have implicated both CB1Rs and CB2Rs in the modulation of gastrointestinal functions, including sensitivity (for review, see Hornby and Prouty, 2004; Di Marzo and Izzo, 2006; Storr and Sharkey, 2007; Storr et al., 2008; Wright et al., 2008).”
BackgroundPreclinical science regarding cannabinoids as analgesics: An overview
Lynch, M. (2005) · Pain Research and Management · doi:10.1155/2005/169093 · Cited by 20
“The upper gastrointestinal tract is strongly influenced by CB1 receptor activation on central vagal pathways, whereas intestinal peristalsis can be modified by CB1 receptor activation in the absence of extrinsic input (78).”
Background
Metadata
- Authors
- Hornby, P. J., & Prouty, S. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 141
- Issue
- 8
- Pages
- 1335-1345
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2124384858
- Cited by
- 103
- References
- 9
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Involvement of cannabinoid receptors in gut motility and visceral perception. https://app.cochat.ai/papers/10.1038/sj.bjp.0705783
- The paper
- Hornby, P. J., & Prouty, S. M. (2004). Involvement of cannabinoid receptors in gut motility and visceral perception. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705783
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.